AGA Family of Websites: Gastro.org
AGA Journals
AGA Journals
AGA University
AGA University
AGA University
AGA Research Foundation
AGA University
AGA Community
AGA University
AGA Job Board

Recognizing the growing impact of eosinophilic GI disorders

Hear from leading experts how to best manage your patients with EoE.
Disorders of swallowing, dysphagia. Pharyngeal and esophageal dysphagia. Oral phase. The path of food, the act of swallowing. Person x-ray, 3d render. Swallowing involves the transport of saliva, solid food and drinks from the mouth to the stomach
Disorders of swallowing, dysphagia. Pharyngeal and esophageal dysphagia. Oral phase. The path of food, the act of swallowing. Person x-ray, 3d render. Swallowing involves the transport of saliva, solid food and drinks from the mouth to the stomach

Over the past two decades, eosinophilic esophagitis (EoE) incidence has grown to approximately 1 case/1,000 persons and it has emerged as a leading cause of dysphagia and food impactions in children and adults around the world. In recognition of National Eosinophil Awareness Week from May 16-22, 2021, AGA presents several EGID-related learning opportunities.

  • Special webinar on EGIDs

    On May 20, noon EDT, AGA will host a special webinar on eosinophilic GI disorders (EGIDs) as part of the Gastro Bites series. A panel will examine cased-based scenarios detailing complications of EoE and discuss optimal diagnosis and treatment strategies for adult and pediatric patients.

  • Why is EoE increasing?

    View an AGA session from DDW® 2019 titled Why is EoE increasing? to identify factors associated with the increasing prevalence of EoE, understand the controversies surrounding use of PPI therapy, and identify treatment options for steroid refractory EoE and eosinophilic gastroenteritis.

  • Clinical Guidelines on EoE

    Access this presentation breaking down the evidence-based recommendations in AGA’s Clinical Guidelines on Management of Eosinophilic Esophagitis.

  • Emerging Therapeutic Approaches

    Take advantage of the on-demand program Emerging Therapeutic Approaches for Managing Eosinophilic Esophagitis, which is supported by an educational grant from Takeda Pharmaceuticals U.S.A, Inc. Ikuo Hirano, MD, and Evan S. Dellon, MD, MPH, will help you to better recognize, diagnose and manage EoE by explaining the pathogenesis of EoE, outlining diagnostic approaches, and teaching you how to develop appropriate treatment plans using novel therapeutic approaches.

Save the date for the 2021 James W. Freston Single Topic Conference on Eosinophils in Gastrointestinal Disease: Pathways and Crossroads, Sept. 18-19, 2021. The 2021 Freston Conference will illuminate clinical features and the natural history of EGIDs including aspects of its genetics, epithelial barrier dysfunction, remodeling, mast cell interactions and food allergies — plus much more! 

Your hub for GI education is
AGA University

By using this site, you agree to our updated Privacy Policy.

X